Eagle Meds Services
CALQUENCE (Acalabrutinib)
Available to sourceHuman Prescription DrugOncology & Specialty

CALQUENCE (Acalabrutinib)

100 mg/1 · Capsule Gelatin Coated
By AstraZeneca Pharmaceuticals LP
NDC
0310-0512
Route
Oral
Therapeutic class
Kinase Inhibitor , Tyrosine Kinase Inhibitors [MoA]
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
CALQUENCE (Acalabrutinib)
NDC 0310-0512